Aristo Bio-Tech and Lifescience Limited (NSE:ARISTO)
108.00
+4.00 (3.85%)
At close: Nov 9, 2026
| Market Cap | 735.24M -15.6% |
| Revenue (ttm) | 3.64B +14.3% |
| Net Income | 71.83M +76.8% |
| EPS | 10.55 +76.8% |
| Shares Out | 6.81M |
| PE Ratio | 10.24 |
| Forward PE | n/a |
| Dividend | 0.60 (0.56%) |
| Ex-Dividend Date | Sep 23, 2026 |
| Volume | 2,400 |
| Open | 108.00 |
| Previous Close | 104.00 |
| Day's Range | 108.00 - 108.00 |
| 52-Week Range | 74.30 - 135.00 |
| Beta | 0.60 |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Nov 13, 2026 |